Volcano Corp (VOLC) 11.83 $VOLC
Downtrend Call Working As Volcano Stock Falls 39.8% (VOLC)
Comtex SmarTrend(R) - Wed Dec 10, 9:39AM CST
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 9 months, Volcano has returned 39.78% as of today's recent price of $11.80.
VOLC: 11.83 (-0.08)
Volcano Has Returned 43.5% Since SmarTrend Recommendation (VOLC)
Comtex SmarTrend(R) - Wed Dec 03, 9:11AM CST
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 8 months, Volcano has returned 43.51% as of today's recent price of $11.07.
VOLC: 11.83 (-0.08)
Volcano Corporation Presentation At Piper Jaffray Conference To Be Webcast
PR Newswire - Tue Nov 25, 7:00AM CST
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today it will be participating in the Piper Jaffray Healthcare Conference on Tuesday, December 2.
VOLC: 11.83 (-0.08)
Volcano Earnings Review: 18 Days after Announcement Shares Up 13.1% (VOLC)
Comtex SmarTrend(R) - Mon Nov 24, 8:41AM CST
Two weeks ago on November 6th, 2014 Volcano (NASDAQ:VOLC) reported earnings and analysts, on average, expected a loss of $0.06 on sales of $95.9 million. The company actually reported a loss of $0.04 per share on sales of $97.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $1.5 million. Since the company's report, shares of Volcano have risen from $9.92 to $11.22, representing a gain of 13.1% in the past 18 days.
VOLC: 11.83 (-0.08)
Shares of VOLC Down 43.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Nov 18, 10:58AM CST
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 8 months, Volcano has returned 43.10% as of today's recent price of $11.15.
VOLC: 11.83 (-0.08)
Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
PR Newswire - Mon Nov 17, 6:00PM CST
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today it will be participating in the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 20.
VOLC: 11.83 (-0.08)
Post Earnings Update: Volcano Has Climbed 10.1% Higher in Past Week (VOLC)
Comtex SmarTrend(R) - Mon Nov 17, 2:53PM CST
When Volcano (NASDAQ:VOLC) reported earnings 11 days ago on November 6th, 2014, analysts, on average, expected the company to report a loss of $0.06 on sales of $95.9 million. Volcano actually reported a loss of $0.04 per share on sales of $97.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $1.5 million. Shares of Volcano have climbed from $9.92 to $10.92, representing a gain of 10.1% since the company reported earnings 11 days ago.
VOLC: 11.83 (-0.08)
Volcano Corp. (VOLC) Stock Higher Today After Analyst Upgrade
at The Street - Mon Nov 17, 9:18AM CST
Shares of Volcano Corp. (VOLC) are up after Credit Suisse upgraded the company to 'outperform' from 'neutral' while lowering its price target to $14 from $16.
VOLC: 11.83 (-0.08)
Upgrade Alert for Volcano (VOLC)
Comtex SmarTrend(R) - Mon Nov 17, 7:52AM CST
Volcano (NASDAQ:VOLC) was upgraded from Neutral to Outperform at Credit Suisse today. The stock closed yesterday at $10.92 on volume of 453,000 shares, below average daily volume of 1.1 million. Over the past year, Volcano has traded in a range of $9.81 to $24.62 and closed yesterday at $10.92, 11% above that low. Over the past week, the 200-day moving average (MA) has gone down 1.5% while the 50-day MA has declined 1.2%.
VOLC: 11.83 (-0.08)
Volcano Shares Down 46.1% Since SmarTrend's Sell Call (VOLC)
Comtex SmarTrend(R) - Tue Nov 11, 9:41AM CST
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 8 months, Volcano has returned 46.11% as of today's recent price of $10.56.
VOLC: 11.83 (-0.08)
Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:10AM CST
Despite Volcano (VOLC) provided disappointing revenue guidance for 2014 on account of expected negative foreign exchange impact, management expects accelerated profitability over the near term.
ABMD: 36.34 (-0.57), VOLC: 11.83 (-0.08), EW: 128.87 (-3.20), ANGO: 18.88 (+0.15)
Global Optical Imaging Market Forecasts and Opportunities, 2019 - Technique, Product & Application Analysis of the $1.6 Billion Industry
M2 - Fri Nov 07, 6:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/cm2sjx/optical_imaging) has announced the addition of the "Optical Imaging Market by Technique, Product & by Application - Global Forecasts to 2019" report to their offering. The global optical imaging market is expected to grow at a strong CAGR of 12.7% from 2014 to reach 1,669.2 million by 2019 The market is mainly driven by increasing research in the pharmaceutical and biotechnology segments, a growing demand for noninvasive modalities for therapeutic and diagnostic applications due to increasing healthcare awareness, and the successful application of optical imaging technology in medical diagnostics and therapeutics in the end-user markets. However, the high cost and data requirements, stringent regulations regarding medical devices, reimbursement challenges, lack of data validation, and operator skills are hampering the growth of this market. During the forecast period, the OCT segment will continue to dominate the optical imaging market. OCT is growing primarily due to its successful clinical applications, especially in ophthalmology. Furthermore, the growing demand for optical imaging in pharmaceutical and biopharmaceutical industries for drug formulation and other usages is also expected to drive the growth of the optical imaging market. By 2019, North America is expected to contribute the largest share to the global optical imaging market, followed by Europe, Asia-Pacific, and RoW. However, developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to Asia-Pacific. The Asia-Pacific region is expected to show the fastest market growth during the forecast period, largely driven by increasing research funding from government and private investors, and the growing number of research laboratories in the region. Major players in this market include Carl Zeiss Meditec AG (Germany), Topcon Medical Systems, Inc. (U.S.), Bioptigen, Inc. (U.S.), St. Jude Medical (U.S.), Volcano Corporation (U.S.), Canon, Inc. (Japan), and PerkinElmer, Inc. (U.S.). Scope of the Report Technique - Optical Coherence Tomography - Hyperspectral Imaging - Photoacoustic Tomography Product - Imaging System - Imaging software Application - Ophthalmology - Neurology - Oncology - Cardiology Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Optical Imaging Market, By Technique 8 Global Optical Imaging Market, By Product 9 Global Optical Imaging Market, By Application 10 Global Optical Imaging Market, By End User 11 Global Optical Imaging Market, By Geography 12 Competitive Landscape 13 Company Profiles - Bioptigen Inc. - Canon Inc. - Carl Zeiss Meditec Ag - Headwall Photonics Inc. - Heidelberg Engineering Inc. - Optovue, Inc. - Perkinelmer Inc. - St. Jude Medical Inc. - Topcon Corporation (Topcon Medical Systems, Inc.) - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/cm...al_imaging
CAJ: 32.86 (+0.45), VOLC: 11.83 (-0.08), STJ: 66.33 (-0.68)
Volcano's (VOLC) CEO Scott Huennekens on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 8:10PM CST
VOLC: 11.83 (-0.08)
Volcano tops Street 3Q forecasts
Automated Insights - Thu Nov 06, 5:04PM CST
SAN DIEGO (AP) _ Volcano Corp. (VOLC) on Thursday reported a loss of $8 million in its third quarter.
VOLC: 11.83 (-0.08)
Volcano beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:22PM CST
VOLC: 11.83 (-0.08)
Volcano Reports Third Quarter Results
PR Newswire - Thu Nov 06, 3:05PM CST
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, today reported results for the third quarter and first nine months of 2014.
VOLC: 11.83 (-0.08)
Technical Coverage on Health Care Equipment Stocks - Boston Scientific, Zeltiq Aesthetics, Globus Medical, Volcano, and Stryker
PR Newswire - Thu Nov 06, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), Globus Medical Inc. (NYSE: GMED), Volcano Corporation (NASDAQ: VOLC), and Stryker Corporation (NYSE: SYK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, November 5, 2014, the NASDAQ Composite ended at 4,620.72, down 0.06%, the Dow Jones Industrial Average advanced 0.58%, to finish the day at 17,484.53, and the S&P 500 closed at 2,023.57, up 0.57%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.22, down 0.19%, while the index has advanced 10.98% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.00 (+0.11), ZLTQ: 29.06 (+0.32), GMED: 23.49 (-0.34), VOLC: 11.83 (-0.08), SYK: 92.00 (-1.41)
Volcano Corporation Presentation At Credit Suisse Conference To Be Webcast
PR Newswire - Tue Nov 04, 7:00AM CST
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today it will be participating in the Credit Suisse 2014 Healthcare Conference on Tuesday, November 11.
VOLC: 11.83 (-0.08)
Downtrend Call Working As Volcano Stock Falls 39.8% (VOLC)
Comtex SmarTrend(R) - Wed Dec 10, 9:39AM CST
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 9 months, Volcano has returned 39.78% as of today's recent price of $11.80.
VOLC: 11.83 (-0.08)
Volcano Has Returned 43.5% Since SmarTrend Recommendation (VOLC)
Comtex SmarTrend(R) - Wed Dec 03, 9:11AM CST
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 8 months, Volcano has returned 43.51% as of today's recent price of $11.07.
VOLC: 11.83 (-0.08)
Volcano Corporation Presentation At Piper Jaffray Conference To Be Webcast
PR Newswire - Tue Nov 25, 7:00AM CST
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today it will be participating in the Piper Jaffray Healthcare Conference on Tuesday, December 2.
VOLC: 11.83 (-0.08)
Volcano Earnings Review: 18 Days after Announcement Shares Up 13.1% (VOLC)
Comtex SmarTrend(R) - Mon Nov 24, 8:41AM CST
Two weeks ago on November 6th, 2014 Volcano (NASDAQ:VOLC) reported earnings and analysts, on average, expected a loss of $0.06 on sales of $95.9 million. The company actually reported a loss of $0.04 per share on sales of $97.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $1.5 million. Since the company's report, shares of Volcano have risen from $9.92 to $11.22, representing a gain of 13.1% in the past 18 days.
VOLC: 11.83 (-0.08)
Shares of VOLC Down 43.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Nov 18, 10:58AM CST
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 8 months, Volcano has returned 43.10% as of today's recent price of $11.15.
VOLC: 11.83 (-0.08)
Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
PR Newswire - Mon Nov 17, 6:00PM CST
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today it will be participating in the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 20.
VOLC: 11.83 (-0.08)
Post Earnings Update: Volcano Has Climbed 10.1% Higher in Past Week (VOLC)
Comtex SmarTrend(R) - Mon Nov 17, 2:53PM CST
When Volcano (NASDAQ:VOLC) reported earnings 11 days ago on November 6th, 2014, analysts, on average, expected the company to report a loss of $0.06 on sales of $95.9 million. Volcano actually reported a loss of $0.04 per share on sales of $97.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $1.5 million. Shares of Volcano have climbed from $9.92 to $10.92, representing a gain of 10.1% since the company reported earnings 11 days ago.
VOLC: 11.83 (-0.08)
Volcano Corp. (VOLC) Stock Higher Today After Analyst Upgrade
at The Street - Mon Nov 17, 9:18AM CST
Shares of Volcano Corp. (VOLC) are up after Credit Suisse upgraded the company to 'outperform' from 'neutral' while lowering its price target to $14 from $16.
VOLC: 11.83 (-0.08)
Upgrade Alert for Volcano (VOLC)
Comtex SmarTrend(R) - Mon Nov 17, 7:52AM CST
Volcano (NASDAQ:VOLC) was upgraded from Neutral to Outperform at Credit Suisse today. The stock closed yesterday at $10.92 on volume of 453,000 shares, below average daily volume of 1.1 million. Over the past year, Volcano has traded in a range of $9.81 to $24.62 and closed yesterday at $10.92, 11% above that low. Over the past week, the 200-day moving average (MA) has gone down 1.5% while the 50-day MA has declined 1.2%.
VOLC: 11.83 (-0.08)
Volcano Shares Down 46.1% Since SmarTrend's Sell Call (VOLC)
Comtex SmarTrend(R) - Tue Nov 11, 9:41AM CST
SmarTrend identified a Downtrend for Volcano (NASDAQ:VOLC) on March 28th, 2014 at $19.60. In approximately 8 months, Volcano has returned 46.11% as of today's recent price of $10.56.
VOLC: 11.83 (-0.08)
Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:10AM CST
Despite Volcano (VOLC) provided disappointing revenue guidance for 2014 on account of expected negative foreign exchange impact, management expects accelerated profitability over the near term.
ABMD: 36.34 (-0.57), VOLC: 11.83 (-0.08), EW: 128.87 (-3.20), ANGO: 18.88 (+0.15)
Global Optical Imaging Market Forecasts and Opportunities, 2019 - Technique, Product & Application Analysis of the $1.6 Billion Industry
M2 - Fri Nov 07, 6:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/cm2sjx/optical_imaging) has announced the addition of the "Optical Imaging Market by Technique, Product & by Application - Global Forecasts to 2019" report to their offering. The global optical imaging market is expected to grow at a strong CAGR of 12.7% from 2014 to reach 1,669.2 million by 2019 The market is mainly driven by increasing research in the pharmaceutical and biotechnology segments, a growing demand for noninvasive modalities for therapeutic and diagnostic applications due to increasing healthcare awareness, and the successful application of optical imaging technology in medical diagnostics and therapeutics in the end-user markets. However, the high cost and data requirements, stringent regulations regarding medical devices, reimbursement challenges, lack of data validation, and operator skills are hampering the growth of this market. During the forecast period, the OCT segment will continue to dominate the optical imaging market. OCT is growing primarily due to its successful clinical applications, especially in ophthalmology. Furthermore, the growing demand for optical imaging in pharmaceutical and biopharmaceutical industries for drug formulation and other usages is also expected to drive the growth of the optical imaging market. By 2019, North America is expected to contribute the largest share to the global optical imaging market, followed by Europe, Asia-Pacific, and RoW. However, developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to Asia-Pacific. The Asia-Pacific region is expected to show the fastest market growth during the forecast period, largely driven by increasing research funding from government and private investors, and the growing number of research laboratories in the region. Major players in this market include Carl Zeiss Meditec AG (Germany), Topcon Medical Systems, Inc. (U.S.), Bioptigen, Inc. (U.S.), St. Jude Medical (U.S.), Volcano Corporation (U.S.), Canon, Inc. (Japan), and PerkinElmer, Inc. (U.S.). Scope of the Report Technique - Optical Coherence Tomography - Hyperspectral Imaging - Photoacoustic Tomography Product - Imaging System - Imaging software Application - Ophthalmology - Neurology - Oncology - Cardiology Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Global Optical Imaging Market, By Technique 8 Global Optical Imaging Market, By Product 9 Global Optical Imaging Market, By Application 10 Global Optical Imaging Market, By End User 11 Global Optical Imaging Market, By Geography 12 Competitive Landscape 13 Company Profiles - Bioptigen Inc. - Canon Inc. - Carl Zeiss Meditec Ag - Headwall Photonics Inc. - Heidelberg Engineering Inc. - Optovue, Inc. - Perkinelmer Inc. - St. Jude Medical Inc. - Topcon Corporation (Topcon Medical Systems, Inc.) - Volcano Corporation For more information visit http://www.researchandmarkets.com/research/cm...al_imaging
CAJ: 32.86 (+0.45), VOLC: 11.83 (-0.08), STJ: 66.33 (-0.68)
Volcano's (VOLC) CEO Scott Huennekens on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 8:10PM CST
VOLC: 11.83 (-0.08)
Volcano tops Street 3Q forecasts
Automated Insights - Thu Nov 06, 5:04PM CST
SAN DIEGO (AP) _ Volcano Corp. (VOLC) on Thursday reported a loss of $8 million in its third quarter.
VOLC: 11.83 (-0.08)
Volcano beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:22PM CST
VOLC: 11.83 (-0.08)
Volcano Reports Third Quarter Results
PR Newswire - Thu Nov 06, 3:05PM CST
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, today reported results for the third quarter and first nine months of 2014.
VOLC: 11.83 (-0.08)
Technical Coverage on Health Care Equipment Stocks - Boston Scientific, Zeltiq Aesthetics, Globus Medical, Volcano, and Stryker
PR Newswire - Thu Nov 06, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), Globus Medical Inc. (NYSE: GMED), Volcano Corporation (NASDAQ: VOLC), and Stryker Corporation (NYSE: SYK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, November 5, 2014, the NASDAQ Composite ended at 4,620.72, down 0.06%, the Dow Jones Industrial Average advanced 0.58%, to finish the day at 17,484.53, and the S&P 500 closed at 2,023.57, up 0.57%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.22, down 0.19%, while the index has advanced 10.98% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.00 (+0.11), ZLTQ: 29.06 (+0.32), GMED: 23.49 (-0.34), VOLC: 11.83 (-0.08), SYK: 92.00 (-1.41)
Volcano Corporation Presentation At Credit Suisse Conference To Be Webcast
PR Newswire - Tue Nov 04, 7:00AM CST
Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today it will be participating in the Credit Suisse 2014 Healthcare Conference on Tuesday, November 11.
VOLC: 11.83 (-0.08)
